Acute Graft-versus-Host Disease of the Gut

A 28-year-old man with acute promyelocytic leukemia at first early relapse received HLAmatched allogenic bone marrow transplantation (BMT) at first early relapse. Cyclosporin A and methotrexate were administered at conventional doses as a prophylaxis for graft-versus-host disease (GVHD). He presente...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 1995, Vol.34(8), pp.751-755
Hauptverfasser: IZUMI, Tohru, AMEMIYA, Youichi, IWAO, Noriaki, SUZUKI, Toshiyuki, MUROI, Kazuo, YOSHIDA, Minoru, HATAKE, Kiyohiko, MIURA, Yasusada, HITOMI, Noribumi, HATAKEYAMA, Makio, NAKAZAWA, Kenji, SAITO, Ken
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A 28-year-old man with acute promyelocytic leukemia at first early relapse received HLAmatched allogenic bone marrow transplantation (BMT) at first early relapse. Cyclosporin A and methotrexate were administered at conventional doses as a prophylaxis for graft-versus-host disease (GVHD). He presented with severe bloody diarrhea on day 87 after BMT. Examination of the lower gastrointestinal tract revealed diffuse mucosal change of inflammation. A diagnosis of late onset of acute gut GVHD was made, in the absence of other manifestations such as skin and liver involvement. A further survey is needed to clarify the incidence and the pathogenesis of atypical gut GVHD. (Internal Medicine 34: 751-755, 1995)
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.34.751